Cart (0 Items)
Your cart is currently empty.
View ProductsIGF1R recombinant protein
| Size | 100ug |
|---|---|
| Brand | |
| Product type | |
| Host Species | |
| Applications |
| Product name | IGF1R recombinant protein |
|---|---|
| Uniprot link | https://www.uniprot.org/uniprot/P08069 |
| Origin species | Homo sapiens (Human) |
| Expression system | Eukaryotic expression |
| Molecular weight | 102.52 kDa |
| Protein delivered with Tag? | C-terminal His Tag |
| Purity estimated | >90% as determined by SDS-PAGE |
| Buffer | PBS, pH7.5 |
| Delivery condition | Dry Ice |
| Storage condition | 4°C for short term (1 week), -20°C or -80°C for long term (avoid freezing/thawing cycles; addition of 20-40% glycerol improves cryoprotection) |
| Brand | ProteoGenix |
| Host species | Mammalian cells |
| Applications | ELISA,WB |
| Fragment Type | Met1-Asn932 |
| Protein Accession | P08069 |
| Aliases /Synonyms | CD221 |
| Reference | PX-P5185 |
| Note | For research use only |
Cixutumumab Biosimilar - Anti-IGF1R, CD221 mAb binds to IGF1R recombinant protein in indirect ELISA Assay
Immobilized IGF1R recombinant protein (cat. No.PX-P5185) at 0.5µg/mL (100µL/well) can bind to Cixutumumab Biosimilar - Anti-IGF1R, CD221 mAb (cat. No.PX-TA1205) in indirect ELISA with Goat Anti-Human IgG secondary antibody coupled with HRP measured by OD450
Related products
Biosimilar
Ganitumab Biosimilar – Anti-IGF1R, CD221 mAb – Research Grade
PX-TA1123 400€
Biosimilar
Cixutumumab Biosimilar – Anti-IGF1R, CD221 mAb – Research Grade
PX-TA1205 400€
Biosimilar
Figitumumab Biosimilar – Anti-IGF1R, CD221 mAb – Research Grade
PX-TA1208 400€
Biosimilar
Robatumumab Biosimilar – Anti-IGF1R, CD221 mAb – Research Grade
PX-TA1210 400€
Biosimilar
Dalotuzumab Biosimilar – Anti-IGF1R, CD221 mAb – Research Grade
PX-TA1239 400€
Biosimilar
Teprotumumab Biosimilar – Anti-IGF1R, CD221 mAb – Research Grade
PX-TA1242 300€
Biosimilar
Istiratumab Biosimilar – Anti-ERBB3, IGF1R, CD221 mAb – Research Grade
PX-TA1381 400€
Ligand
Reviews
Il n’y a pas encore d’avis.